Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01623167
Recruitment Status : Recruiting
First Posted : June 19, 2012
Last Update Posted : November 14, 2018
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 30, 2019
  Estimated Study Completion Date : January 30, 2024
Publications automatically indexed to this study by Identifier (NCT Number):